Citizens JMP Initiates Coverage of Microbot Medical with Buy Rating

Citizens JMP has begun coverage of Microbot Medical Inc. (MBOT) with a Buy rating and established a price target of $2.50 per share. This marks the initiation of new market coverage for the medical device company.